Galapagos | GLPG - Operating Expenses

Stock Price
25.60
Daily Change
-0.34 -1.31%
Monthly
-9.86%
Yearly
15.94%
Q2 Forecast
24.95

Galapagos reported EUR120.26M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
argenx SE USD 914.57M 137.58M Dec/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
Biogen USD 1.88B 81.4M Sep/2025
Genmab DKK 798M 235M Dec/2025
Gilead Sciences USD 4.96B 707M Dec/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
GRIFOLS EUR 1.71B 193M Dec/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Incyte USD 1.12B 3.53B Dec/2025
Merck EUR 4.78B 669M Dec/2025
Neurocrine Biosciences USD 577.6M 22M Dec/2025
Novartis USD 9.8B 61M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
UCB EUR 2.96B 196M Dec/2025
Vertex Pharmaceuticals USD 1.93B 89.1M Dec/2025